{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:28:34Z","timestamp":1787506114847,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lembaga Pengelola Dana Pendidikan\/LPDP"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejpb.2020.06.025","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T21:00:05Z","timestamp":1594155605000},"page":"50-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":188,"special_numbering":"C","title":["Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis"],"prefix":"10.1016","volume":"154","author":[{"given":"Andi Dian","family":"Permana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Volpe-Zanutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qonita Kurnia","family":"Anjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Utomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.06.025_b0005","first-page":"1","article-title":"Candida albicans infections","author":"Dowd","year":"2014","journal-title":"Ref. Modul. Biomed. Sci."},{"key":"10.1016\/j.ejpb.2020.06.025_b0010","article-title":"Quinine improves the fungicidal effects of antimicrobial blue lght: Implications for the treatment of cutaneous candidiasis","volume":"1\u20137","author":"Leanse","year":"2019","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.ejpb.2020.06.025_b0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/viru.26187","article-title":"Invasive candidiasis as a cause of sepsis in the critically ill patient","volume":"5","author":"Delaloye","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.ejpb.2020.06.025_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12478053","article-title":"Experimental cutaneous candidiasis in rodents","volume":"66","author":"Ray","year":"1976","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2020.06.025_b0025","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejpb.2020.06.025_b0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/08982101003596125","article-title":"Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis","volume":"20","author":"Gupta","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2020.06.025_b0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.det.2007.01.002","article-title":"Advances in topical and systemic antifungals","volume":"25","author":"Zhang","year":"2007","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ejpb.2020.06.025_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11040195","article-title":"Characteristics of skin deposition of itraconazole solubilized in cream formulation","volume":"11","author":"Kim","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2020.06.025_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-200161001-00004","article-title":"Clinical experience with itraconazole in systemic fungal infections","volume":"61","author":"Boogaerts","year":"2001","journal-title":"Drugs."},{"key":"10.1016\/j.ejpb.2020.06.025_b0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/nnm.10.68","article-title":"Itraconazole-loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activity","volume":"5","author":"Patel","year":"2010","journal-title":"Nanomedicine."},{"key":"10.1016\/j.ejpb.2020.06.025_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mimet.2019.01.020","article-title":"Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies","volume":"161","author":"Alhowyan","year":"2019","journal-title":"J. Microbiol. Methods."},{"key":"10.1016\/j.ejpb.2020.06.025_b0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000018256","article-title":"The use of itraconazole to treat cutaneous fungal infections in children","volume":"199","author":"Gupta","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.ejpb.2020.06.025_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/ijdd.ijdd_20_17","article-title":"Itraconazole: What clinicians should know?","volume":"3","author":"De Doncker","year":"2017","journal-title":"Indian J. Drugs Dermatol."},{"key":"10.1016\/j.ejpb.2020.06.025_b0070","first-page":"35","article-title":"Cutaneous fungal infections","volume":"40","author":"Clinard","year":"2015","journal-title":"US Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2017.04.057","article-title":"Gastrointestinal behavior of itraconazole in humans \u2013 Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution","volume":"526","author":"Berben","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.02.045","article-title":"Drug nanocrystals: Fabrication methods and promising therapeutic applications","volume":"562","author":"Mohammad","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","article-title":"Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation","volume":"62","author":"Keck","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2008.11.029","article-title":"Development of an oral rutin nanocrystal formulation","volume":"370","author":"Mauludin","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0095","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.drudis.2017.10.013","article-title":"Microarray patches: potentially useful delivery systems for long-acting nanosuspensions","volume":"23","author":"Donnelly","year":"2018","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.ejpb.2020.06.025_b0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijpharm.2017.08.108","article-title":"Dermal miconazole nitrate nanocrystals \u2013 formulation development, increased antifungal efficacy & skin penetration","volume":"531","author":"Pyo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2019.04.016","article-title":"Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance study","volume":"563","author":"Tomi\u0107","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejpb.2019.02.004","article-title":"Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals","volume":"137","author":"Soisuwan","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0115","article-title":"Nano-crystallization as a tool for the enhancement of beclomethasone dipropionate dermal deposition: Formulation, in vitro characterization and ex vivo study","volume":"54","author":"Assem","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2020.06.025_b0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/pharmaceutics11070346","article-title":"Enhanced intradermal delivery of nanosuspensions of antifilariasis drugs using dissolving microneedles: A proof of concept study","volume":"11","author":"Permana","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2020.06.025_b0125","series-title":"Microneedle-mediated transdermal and intradermal drug delivery","author":"Donnelly","year":"2012"},{"key":"10.1016\/j.ejpb.2020.06.025_b0130","article-title":"Bacterially sensitive nanoparticle-based dissolving microneedles of doxycycline for enhanced treatment of bacterial biofilm skin infection: A proof of concept study","volume":"119220","author":"Permana","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.10.004","article-title":"Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis","volume":"316","author":"Permana","year":"2019","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2020.06.025_b0140","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/pharmaceutics11070308","article-title":"Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin","volume":"11","author":"Abdelghany","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2020.06.025_b0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2018.11.002","article-title":"Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension","volume":"292","author":"McCrudden","year":"2018","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2020.06.025_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jin2.41","article-title":"Novel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug","volume":"3","author":"Vora","year":"2018","journal-title":"J. Interdiscip. Nanomed."},{"key":"10.1016\/j.ejpb.2020.06.025_b0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2015.11.047","article-title":"Simple low-cost miniaturization approach for pharmaceutical nanocrystals production","volume":"501","author":"Romero","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/pharmaceutics11110606","article-title":"Enhancement in site-specific delivery of carvacrol against methicillin resistant staphylococcus aureus induced skin infections using enzyme responsive nanoparticles: A proof of concept study","volume":"11","author":"Mir","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2020.06.025_b0165","unstructured":"M.P. Weinstein, B.L. Zimmer, J.B. Patel, R.F. Cockerill, A.P. Bradford, M.G. Eliopoulos, A.J. Hindler, G.S. Jenkins, S.J. Lewis, B. Limbago, A.L. Miller, P.D. Nicolau, M. Pwell, M.J. Swenson, M.M. Traczewski, J.D. Turnidge, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Tenth Edition, vol. 35, CLSI (Clinical Lab. Stand. Institute), 2015."},{"key":"10.1016\/j.ejpb.2020.06.025_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2019.12.008","article-title":"Enhancement in site-specific delivery of carvacrol for potential treatment of infected wounds using infection responsive nanoparticles loaded into dissolving microneedles: A proof of concept study","volume":"147","author":"Mir","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0175","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2147\/IDR.S175978","article-title":"In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus","volume":"11","author":"Chen","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejpb.2020.06.025_b0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2017.07.032","article-title":"Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis","volume":"265","author":"Gonz\u00e1lez-V\u00e1zquez","year":"2017","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2020.06.025_b0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.ejpb.2020.06.025_b0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2007.12.004","article-title":"Size analysis of submicron particles by laser diffractometry\u201390% of the published measurements are false","volume":"355","author":"Keck","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","article-title":"Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products","volume":"364","author":"Van Eerdenbrugh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0205","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3109\/03639045.2016.1151036","article-title":"Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying, Drug Dev","volume":"42","author":"Paredes","year":"2016","journal-title":"Ind. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.025_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111846","article-title":"Phytosomal nanocarriers as platforms for improved delivery of natural antioxidant and photoprotective compounds in propolis: An approach for enhanced both dissolution behaviour in biorelevant media and skin retention profiles","volume":"205","author":"Permana","year":"2020","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ejpb.2020.06.025_b0215","first-page":"217","article-title":"Kinetic modelling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm. - Drug Res."},{"key":"10.1016\/j.ejpb.2020.06.025_b0220","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389200215666141125121511","article-title":"Drug interactions between nine antifungal agents and drugs metabolized by human Cytochromes P450","volume":"15","author":"Niwa","year":"2014","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2020.06.025_b0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1043-6618(02)00088-9","article-title":"Itraconazole solution: Summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons","volume":"46","author":"Koks","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejpb.2020.06.025_b0230","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1086\/376523","article-title":"Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis","volume":"37","author":"Steinbach","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejpb.2020.06.025_b0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.diagmicrobio.2013.11.010","article-title":"Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values","volume":"78","author":"Tato","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejpb.2020.06.025_b0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","article-title":"Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs","volume":"180","author":"McCrudden","year":"2014","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2020.06.025_b0245","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11095-014-1301-y","article-title":"Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application : A pilot study centred on pharmacist intervention and a patient information leaflet","volume":"31","author":"Donnelly","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.025_b0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2010.08.008","article-title":"Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution","volume":"147","author":"Donnelly","year":"2010","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2020.06.025_b0255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijpharm.2015.08.049","article-title":"A novel scalable manufacturing process for the production of hydrogel-forming microneedle arrays","volume":"494","author":"Lutton","year":"2015","journal-title":"Int. J. Pharm."}],"updated-by":[{"DOI":"10.1016\/j.ejpb.2025.114929","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000}},{"DOI":"10.1016\/j.ejpb.2025.114929","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:41:55Z","timestamp":1768729315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120301909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"alternative-id":["S0939641120301909"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.025","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}